FdaApplication
BLA 761498
Identifiers
- fda_app_no: BLA761498
Properties
| Property | Value |
|---|---|
| applicant_name | CELLTRION, Inc. |
| application_type | BLA |
| approval_date | 2025-01-24 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AVTOZMA | TOCILIZUMAB-ANOH | 400MG/20ML(20MG/ML) | INJECTABLE;IV (INFUSION) |
| AVTOZMA | TOCILIZUMAB-ANOH | 162MG/0.9ML | Injection |
| AVTOZMA | TOCILIZUMAB-ANOH | 162MG/20ML(20MG/ML) | INJECTABLE;SUBCUTANEOUS |
| AVTOZMA | TOCILIZUMAB-ANOH | 162MG/0.9ML | Injection |
4 products